Donald Trump has unveiled a significant expansion of his prescription drug discount website, TrumpRx, promising to nearly septuple the number of medications available through the program. This announcement comes after experts earlier questioned the site’s limited drug listings, suggesting they catered to a narrow patient demographic.
During a speech on Monday, Trump stated that his administration is “adding over 600 affordable generics to the website,” aiming to provide consumers with “one source to ensure that they are getting the lowest possible cost on their prescription.” He claimed that TrumpRx would offer “the best and lowest prices on prescriptions used by tens of millions of Americans,” and in certain cases, the discounted generics could be cheaper than out-of-pocket insurance costs.
Trump also mentioned the development of new tools for the site, such as a feature to connect patients to the lowest-cost pharmacy nearby or facilitate home delivery of discounted prescriptions. Joe Gebbia, Trump’s chief design officer and co-founder of Airbnb, highlighted a new price-comparison tool, drawing comparisons to the ease of comparing prices for hotels, Airbnbs, or baseball tickets. Additionally, the site includes a “Presidential Deals” section featuring some of the most affordable brand-name drugs in the U.S.
Despite the ambitious rollout of TrumpRx, some experts remain skeptical about its effectiveness for many patients. Sean Sullivan, a professor of health economics and policy at the University of Washington, argued that consumers might find cheaper versions of these medicines through insurance, pharmacies, or cash pay services like Cost Plus Drugs, rather than TrumpRx’s offerings.
Echoing these concerns, Rena Conti, an associate professor at Boston University’s Questrom School of Business, highlighted the complexity of healthcare and prescription drug supply in America. She argued that instead of simplifying the system, TrumpRx adds another layer of complexity for consumers navigating their healthcare options.